The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Open accessAbstract
Peripartum cardiomyopathy (PPCM) is a life-threatening pregnancy-associated cardiomyopathy in previously healthy women. Although PPCM is driven in part by the 16-kDa N-terminal prolactin fragment (16K PRL), the underlying molecular mechanisms are poorly understood. We found that 16K PRL induced microRNA-146a (miR-146a) expression in ECs, which attenuated angiogenesis through downregulation of NRAS. 16K PRL stimulated the release of miR-146a-loaded exosomes from ECs. The exosomes were absorbed by cardiomyocytes, increasing miR-146a levels, which resulted in a subsequent decrease in metabolic activity and decreased expression of Erbb4, Notch1, and Irak1. Mice with cardiomyocyte-restricted Stat3 knockout (CKO mice) exhibited a PPCM-like phenotype and displayed increased cardiac miR-146a expression with coincident downregulation of Erbb4, Nras, Notch1, and Irak1. Blocking miR-146a with locked nucleic acids or antago-miRs attenuated PPCM in CKO mice without interrupting full-length prolactin signaling, as indicated by normal nursing activities. Finally, miR-146a was elevated in the plasma and hearts of PPCM patients, but not in patients with dilated cardiomyopathy. These results demonstrate that miR-146a is a downstream-mediator of 16K PRL that could potentially serve as a biomarker and therapeutic target for PPCM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · cited 3×
“MicroRNAs (miRNAs) are short (19–24 nt), noncoding small RNAs that repress gene expression posttranscriptionally by targeting the 3 ′ -untranslated regions (3 ′ UTRs) of specific mRNAs (12). miRNAs that stimulate or repress angiogenesis have opened up novel therapeutic options in pathophysiologies…”
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
van Rooij, E., Sutherland, L. B., Liu, N., Williams, A. H., McAnally, J., Gerard, R. D., Richardson, J. A., & Olson, E. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608791103 · Cited by 1,507
Tili, E., Michaille, J.-J., Cimino, A., Costinean, S., Dumitru, C. D., Adair, B., Fabbri, M., Alder, H., Liu, C. G., Calin, G. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5082 · Cited by 1,304
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy
Hilfiker-Kleiner, D., Kaminski, K., Podewski, E., Bonda, T., Schaefer, A., Sliwa, K., Forster, O., Quint, A., Landmesser, U., Doerries, C., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.036 · Cited by 906
Self-citationKeene, J. D., Komisarow, J. M., & Friedersdorf, M. B. (2006) · Nature Protocols · doi:10.1038/nprot.2006.47 · Cited by 616
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy
Patten, I. S., Rana, S., Shahul, S., Rowe, G. C., Jang, C., Liu, L., Hacker, M. R., Rhee, J. S., Mitchell, J., Mahmood, F., et al. (2012) · Nature · doi:10.1038/nature11040 · Cited by 572
Self-citationSliwa, K., Blauwet, L., Tibazarwa, K., Libhaber, E., Smedema, J.-P., Becker, A., McMurray, J., Yamac, H., Labidi, S., Struman, I., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.901496 · Cited by 495
Self-citationConditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
Özcelik, C., Erdmann, B., Pilz, B., Wettschureck, N., Britsch, S., Hübner, N., Chien, K. R., Birchmeier, C., & Garratt, A. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122249299 · Cited by 473
AngiomiRs—Key regulators of angiogenesis
Wang, S., & Olson, E. N. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.002 · Cited by 450
Hilfiker-Kleiner, D., Hilfiker, A., Fuchs, M., Kaminski, K., Schaefer, A., Schieffer, B., Hillmer, A., Schmiedl, A., Ding, Z., Podewski, E., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000134921.50377.61 · Cited by 385
Self-citationMicroRNAs: novel regulators in cardiac development and disease
Thum, T., Catalucci, D., & Bauersachs, J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn137 · Cited by 377
MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation
Boon, R. A., Seeger, T., Heydt, S., Fischer, A., Hergenreider, E., Horrevoets, A. J. G., Vinciguerra, M., Rosenthal, N., Sciacca, S., Pilato, M., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.255737 · Cited by 366
Neuregulin in Cardiovascular Development and Disease
Odiete, O., Hill, M. F., & Sawyer, D. B. (2012) · Circulation Research · doi:10.1161/circresaha.112.267286 · Cited by 294
Struman, I., Bentzien, F., Lee, H., Mainfroid, V., D’Angelo, G., Goffin, V., Weiner, R. I., & Martial, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1246 · Cited by 279
Self-citationDetecting microRNA binding and siRNA off-target effects from expression data
van Dongen, S., Abreu-Goodger, C., & Enright, A. J. (2008) · Nature Methods · doi:10.1038/nmeth.1267 · Cited by 273
Corbacho, A., Martinez De La Escalera, G., & Clapp, C. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730219 · Cited by 256
MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells
Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., Lambert, V., Gonzalez, M.-L. A., Colige, A., Rakic, J.-M., Noël, A., Martial, J. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016979 · Cited by 254
Self-citationTargeting microRNA expression to regulate angiogenesis
Kuehbacher, A., Urbich, C., & Dimmeler, S. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.014 · Cited by 248
D'Angelo, G., Struman, I., Martial, J., & Weiner, R. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6374 · Cited by 227
Self-citationHorie, T., Ono, K., Nishi, H., Nagao, K., Kinoshita, M., Watanabe, S., Kuwabara, Y., Nakashima, Y., Takanabe-Mori, R., Nishi, E., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq148 · Cited by 208
Role of Neuregulin-1/ErbB2 Signaling in Endothelium-Cardiomyocyte Cross-talk
Lemmens, K., Segers, V. F. M., Demolder, M., & De Keulenaer, G. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600399200 · Cited by 192
Endothelium-Derived Neuregulin Protects the Heart Against Ischemic Injury
Hedhli, N., Huang, Q., Kalinowski, A., Palmeri, M., Hu, X., Russell, R. R., & Russell, K. S. (2011) · Circulation · doi:10.1161/circulationaha.110.991125 · Cited by 173
MicroRNA-146a Inhibits Glioma Development by Targeting Notch1
Mei, J., Bachoo, R., & Zhang, C.-L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05821-11 · Cited by 171
Hilfiker-Kleiner, D., Shukla, P., Klein, G., Schaefer, A., Stapel, B., Hoch, M., Müller, W., Scherr, M., Theilmeier, G., Ernst, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.933127 · Cited by 167
Self-citationThe role of Neuregulin-1β/ErbB signaling in the heart
Pentassuglia, L., & Sawyer, D. B. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.08.015 · Cited by 162
Berndt, S., Perrier d'Hauterive, S., Blacher, S., Péqueux, C., Lorquet, S., Munaut, C., Applanat, M., Astrid Hervé, M., Lamandé, N., Corvol, P., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5885fje · Cited by 161
Haghikia, A., Missol‐Kolka, E., Tsikas, D., Venturini, L., Brundiers, S., Castoldi, M., Muckenthaler, M. U., Eder, M., Stapel, B., Thum, T., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq369 · Cited by 131
Self-citationRas-MAP Kinase Signaling Pathways and Control of Cell Proliferation: Relevance to Cancer Therapy
Shapiro, P. S. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795538 · Cited by 124
MicroRNA-221–222 Regulate the Cell Cycle in Mast Cells
Mayoral, R. J., Pipkin, M. E., Pachkov, M. V., van Nimwegen, E., Rao, A., & Monticelli, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.433 · Cited by 111
Peripartum Cardiomyopathy: Recent Insights in its Pathophysiology
Hilfiker‐Kleiner, D., Sliwa, K. S., & Drexler, H. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.05.002 · Cited by 105
Self-citationInfluence of plasminogen activator inhibitor type 1 on choroidal neovascularization
Lambert, V., Munaut, C., Noël, A., Frankenne, F., Bajou, K., Gerard, R. D., Carmeliet, P., Defresne, M. P., Foidart, J., & Rakic, J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0393com · Cited by 98
Self-citationTabruyn, S. P., Sorlet, C., Rentier‐Delrue, F., Bours, V., Weiner, R. I., MARTIAL, J. A., & Struman, I. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0132 · Cited by 92
Self-citationHilfiker‐Kleiner, D., Hilfiker, A., Kamiński, K. A., Schaefer, A., Park, J.-K., Michel, K., Guba‐Quint, A., Yaniv, M., Weitzman, J. B., & Drexler, H. (2005) · Circulation · doi:10.1161/circulationaha.104.518472 · Cited by 85
Self-citationLee, S.-H., Kunz, J., Lin, S.-H., & Yu‐Lee, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0986 · Cited by 62
Molecular Targeting of Antiangiogenic Factor 16K hPRL Inhibits Oxygen-Induced Retinopathy in Mice
Pan, H., Nguyen, N.-Q.-N., Yoshida, H., Bentzien, F., Shaw, L. C., Rentier‐Delrue, F., MARTIAL, J. A., Weiner, R. I., Struman, I., & Grant, M. B. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1001 · Cited by 57
Self-citationBentzien, F., Struman, I., Martini, J.-F., MARTIAL, J. A., & Weiner, R. I. (2001) · PubMed · Cited by 55
Self-citationTabruyn, S. P., Nguyen, N.-Q.-N., Cornet, A. M., MARTIAL, J. A., & Struman, I. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0515 · Cited by 52
Self-citationNF-κB activation in endothelial cells is critical for the activity of angiostatic agents
Tabruyn, S. P., Mémet, S., Avé, P., Verhaeghe, C., Mayo, K. H., Struman, I., MARTIAL, J. A., & Griffioen, A. W. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0383 · Cited by 47
Self-citation
Cited by
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
Self-citationBang, C., Batkai, S., Dangwal, S., Gupta, S. K., Foinquinos, A., Holzmann, A., Just, A., Remke, J., Zimmer, K., Zeug, A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70577 · Cited by 979
Exosomes as Critical Agents of Cardiac Regeneration Triggered by Cell Therapy
Ibrahim, A. G.-E., Cheng, K., & Marbán, E. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.04.006 · Cited by 826
Sorting it out: Regulation of exosome loading
Villarroya-Beltri, C., Baixauli, F., Gutiérrez-Vázquez, C., Sánchez-Madrid, F., & Mittelbrunn, M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.04.009 · Cited by 742
Application of exosomes as liquid biopsy in clinical diagnosis
Zhou, B., Xu, K., Zheng, X., Chen, T., Wang, J., Song, Y., Shao, Y., & Zheng, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00258-9 · Cited by 685
Metadata
- Authors
- Halkein, J., Tabruyn, S. P., Ricke-Hoch, M., Haghikia, A., Nguyen, N.-Q.-N., Scherr, M., Castermans, K., Malvaux, L., Lambert, V., Thiry, M., Sliwa, K., Noel, A., Martial, J. A., Hilfiker-Kleiner, D., & Struman, I.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-04-24
- Volume
- 123
- Issue
- 5
- Pages
- 2143-2154
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2137081126
- Cited by
- 499
- References
- 44
- FWCI
- 25.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.